NAS_ADMA.pdf
0.19MB
PSR 5배 정도
목표주가 평균 8
면역 폐렴
ADMA Biologics, Inc.
Discover ADMA Biologics Patented Immunotechnology* Designed for the Immunocompromised We manufacture, develop and commercialize specialized, targeted, plasma-derived therapeutics to extend and enhance the lives of individuals who are naturally or medically
www.admabiologics.com
ADMA Corporate Deck 11092020.pdf
9.86MB
728x90
'---매수대상--- > 미국 스몰캡 주당 10불 이하' 카테고리의 다른 글
| TXMD (0) | 2021.02.01 |
|---|---|
| GLMD GALMED PHARMACEUTICALS 갈메드 (0) | 2021.01.29 |
| LIFE ATVR PHARMA (0) | 2021.01.29 |
| ATPO 압토즈 바이오 (0) | 2020.12.11 |
| PROG 여성 치료 전용 바이오 (0) | 2020.12.10 |
댓글